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Recent insights into the genetic basis of neurological disease have led to the 
hypothesis that molecular pathways involved in synaptic growth, development, and 
stability are perturbed in a variety of mental disorders. Formation of a functional synapse 
is a complex process requiring stabilization of initial synaptic contacts by adhesive 
protein interactions, organization of pre- and post-synaptic specializations by scaffolding 
proteins, regulation of growth by intercellular signaling pathways, reorganization of the 
actin cytoskeleton, and proper endosomal trafficking of synaptic growth signaling 
complexes. Many neuropsychiatric disorders, including autism, schizophrenia, and 
intellectual disability, have been linked to inherited mutations which perturb these 
processes. Our understanding of the basic biology of synaptogenesis is therefore critical 
to unraveling the pathogenesis of neuropsychiatric disorders. 
 
Introduction 
 The formation of a functional, mature neuronal synapse requires a host of 
molecular players to mediate coordinated pre- and post-synaptic growth. In recent years, 
clinically diverse disorders such as autism spectrum disorders (ASDs), schizophrenia, 
epilepsy, and intellectual disability (ID) have been linked to dysfunction of a number of 
proteins implicated in synaptic development [1,2]. For example, deletions of neurexin-1α, 
a synaptic cell adhesion protein, were initially identified by large-scale genetic screens in 
patients with autism and schizophrenia, and subsequently found in patients with severe 
ID and epilepsy [3]. Mutations in genes encoding the SHANK postsynaptic scaffolding 
protein family were first identified in a patient with ID, and later associated with autism 
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and schizophrenia [4,5]. As the number of genes contributing to neuropsychiatric 
disorders has grown, it has become increasingly clear that pathways contributing to 
synaptic development and activity-dependent growth are important in their etiology. 
 Here, we examine genes implicated in synaptogenesis which have been associated 
with neurological disease. In particular, we highlight the role of these genes in synaptic 
cell adhesion, organization of pre- and post-synaptic specializations, growth signaling 
pathways, and endosomal function. Insights into the function of these genes at the 
Drosophila neuromuscular junction (NMJ) are emphasized, as this model glutamatergic 
synapse is well studied within the context of activity-dependent synaptic development.  
  
Specification and stabilization of the synapse is mediated by cell adhesion proteins 
One of the earliest steps in synaptogenesis is the induction and adhesion of 
precisely opposed pre- and post-synaptic domains. Multiple transsynaptic cell adhesion 
complexes operate in parallel to ensure proper synaptic alignment (Figure 1). Mutation of 
synaptic adhesion proteins has been linked to various neuropsychiatric disorders, 
indicating that abnormal formation or maintenance of synaptic contacts may be impaired 
in several neurological diseases [6]. Members of the cadherin and immunoglobulin 
protein superfamilies play an important role in mediating synaptic adhesion. Synaptic cell 
adhesion molecule 1 (SynCAM1) is an immunoglobulin domain containing protein found 
on axonal growth cones, and is one of the first transsynaptic adhesion molecules to 
assemble at developing synapses [7]. Homophilic binding of SynCAM1 across the 
synaptic cleft promotes synapse formation in cultured hippocampal neurons [7]. Recently, 
missense mutations in SynCAM1 have been identified in patients with ASDs, and a 
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SynCAM1 knock-out mouse was found to have impaired social behaviors [8,9]. 
Mutations in a Drosophila SynCAM-like protein, FasII, disrupt synaptic growth at the 
NMJ due to synaptic destabilization [10]. Several members of the cadherin protein family, 
including protocadherins, also mediate transsynaptic adhesion and have been linked to 
ASDs in genome-wide association studies [11,12]. The role of cadherins and 
protocadherins in synaptogenesis is poorly understood, although they likely participate in 
synapse formation and refinement. 
One well studied transsynaptic adhesion complex is neurexin-neuroligin. 
Mutations in neurexins and neuroligins have been identified in several families with 
heritable neurological disorders, including ASDs, schizophrenia, and ID [13]. The 
binding of a presynaptic neurexin to a postsynaptic neuroligin is required for synapse 
function, but whether neurexin-neuroligin binding affects synapse formation is unclear 
[13]. In Drosophila, mutations in the homolog of neurexin, dnrx, cause reduced synaptic 
growth and defective presynaptic active zone formation [14]. Likewise, mutations in 
neuroligin, dnlg1, decrease synaptic growth due to deficits in bouton addition and 
postsynaptic differentiation [15]. In mammals, a synaptogenic role for neurexins is 
suggested by the observation that neurexins bind the postsynaptic glutamate receptor δ2 
via an adaptor protein, which is essential for excitatory synaptogenesis in the cerebellum 
[16].  
 Another family of postsynaptic cell adhesion proteins, the leucine-rich repeat 
transmembrane proteins (LRRTMs), were identified in a screen for synaptogenic proteins 
and subsequently found to bind neurexins [17-19]. Similar to neurexins and neuroligins, 
mutations in LRRTMs have been associated with both autism and schizophrenia, and are 
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thought to promote synapse formation [20,21]. The netrin-G ligand (NGL) proteins form 
a subfamily of LRRTM synaptic adhesion molecules implicated in the etiology of 
schizophrenia and biopolar disorder [22,23]. NGLs promote excitatory synaptogenesis by 
binding to presynaptic netrin G and LAR receptors, as well as postsynaptic proteins [23]. 
The combinatorial action of neurexins, neuroligins, LRRTMs, and NGLs is not well 
understood, and these complexes may act redundantly at the synapse. 
 Several other cell adhesion proteins whose synaptic role is unclear have also been 
associated with neurological disease. Contactin-associated protein-2 (CNTNAP2) is a 
single-pass transmembrane protein distantly related to neurexins, and is associated with 
ASDs, schizophrenia, ID, and epilepsy by genome-wide linkage analysis [24]. A synaptic 
role for CNTNAP2 was recently demonstrated in Drosophila, in which neuronal 
knockdown of CNTNAP2 (NrxIV) resulted in aberrant synaptic morphology and 
misregulation of a critical active zone component [3]. Another recently recognized 
synaptic cell adhesion molecule is amyloid precursor protein (APP), a type I membrane 
protein involved in Alzheimer’s disease pathogenesis. APP was found to promote 
synaptogenesis in culture and is required both pre- and post-synaptically to regulate 
mammalian NMJ structure and function, presumably by forming a transsynaptic adhesion 
complex [25]. Similarly, regulation of the Drosophila APP homolog critically controls 
synaptic growth at the NMJ [26]. The involvement of various synaptic cell adhesion 
proteins in neuropsychiatric diseases indicates that abnormal synapse formation or 
specification may be a common risk factor for mental disorders. 
 
Organization of pre- and post-synaptic domains by scaffolding proteins 
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Formation of a functional synapse requires assembly of synaptic proteins into 
domains specialized for neurotransmitter release and reception. Scaffolding proteins are 
critical mediators of this process on both sides of the synapse. Scaffolds are composed of 
multiple protein-protein interaction domains, and form a physical link between adhesion 
proteins, ion channels, neurotransmitter receptors, intracellular signaling cascades, and 
the actin cytoskeleton. 
One of the strongest links between synaptic organization and neurological disease 
is the SHANK family of scaffolding proteins. SHANK proteins localize to the excitatory 
postsynaptic density and contain multiple protein-protein interaction domains. Mutations 
in SHANK2 and SHANK3 have been identified in patients with autism, mental 
retardation, and schizophrenia [4,5]. In conjunction with HOMER, SHANKs form a 
mesh-like matrix at the postsynaptic density which regulates the morphology of dendritic 
spines and recruits postsynaptic density proteins [27]. The connection between SHANK 
scaffolds and mental dysfunction was recently strengthened by the finding that FMRP, 
the RNA binding protein mutated in Fragile X syndrome, inhibits the translation of 
SHANK1 [28]. Fragile X syndrome is the most common inherited form of mental 
retardation and is associated with abnormal dendritic morphology. Deregulated synthesis 
of SHANK scaffolds may contribute to this abnormal morphology.            
The membrane-associated guanylate kinase (MAGUK) scaffolding protein family 
has multiple members that are present pre- and post-synaptically. One MAGUK family 
member, CASK, is a causative gene in X-linked mental retardation [29]. CASK is an 
essential vertebrate protein involved in assembly and functional maturation of the 
synapse [30]. Interestingly, CASK directly interacts with neurexin-1, which it 
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phosphorylates in a developmentally regulated manner [29], although the functional 
significance of neurexin phosphorylation is unclear. CASK also interacts with the 
adhesion protein SynCAM1, which recruits CASK from cytosol to the membrane [31]. 
The strong association of mutations in presynaptic CASK and postsynaptic SHANKs 
with neurological disease highlights an important role for synaptic scaffolding proteins. 
 
Activity-dependent synaptic development depends on intercellular signaling 
pathways 
 Once a synapse has formed, neuronal activity plays an essential role in shaping 
and maintaining synaptic connections [32]. Anterograde and retrograde secreted signaling 
molecules, including the Wnts and BMPs, regulate synaptic growth (Figure 1) and may 
also contribute to the development of neurological disease.  The Wnt family of signaling 
molecules participates in a broad range of processes, from neurogenesis to synaptic 
plasticity. Several Wnt pathway components have been implicated in the pathogenesis of 
schizophrenia and Alzheimer’s, raising the question of how this pathway functions at the 
synapse [33,34]. At the Drosophila NMJ, the Wnt pathway signals bidirectionally to 
mediate synaptic growth in response to patterned neuronal stimulation [35]. 
Presynaptically, Wnt regulates cytoskeletal dynamics through inhibition of glycogen 
synthase kinase 3β (GSK-3β), a cytoplasmic pathway component which interacts with the 
microtubule and actin cytoskeletons. Single nucleotide polymorphisms in GSK-3β are 
associated with schizophrenia, and GSK-3β was recently found to interact with DISC1, a 
major schizophrenia susceptibility gene [33,36]. Postsynaptically, Wnt signaling causes 
translocation of the cleaved receptor Frizzled into the nucleus, which promotes growth of 
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the postsynaptic membrane [35,37]. Polymorphisms in Wnt signaling components have 
been linked to neurodegenerative diseases such as Alzheimer’s, though whether this late-
onset disease is related to Wnt’s synaptogenic function is unclear [38].     
A second synaptic growth signaling pathway is the bone morphogenetic protein 
(BMP) pathway, dysregulation of which is associated with multiple neurodegenerative 
diseases [39]. Retrograde BMP signaling at the Drosophila NMJ is initiated by release of 
the BMP ligand Gbb by the muscle, which triggers a signaling cascade in the presynaptic 
neuron [40]. BMP signaling activates a transcription factor which targets multiple genes, 
including a recently described Rac GTPase activator [40]. Rac GTPases regulate the actin 
cytoskeleton and are important for growth of dendritic spines, which mechanistically 
links BMP signaling to structural synaptic plasticity [41]. Recently, synaptic Rac1 
GTPase activity was shown to be regulated by FMRP and DISC1, raising the possibility 
that both Fragile X and schizophrenia may have impaired BMP mediated activity-
dependent synaptic growth [42,43].  
 
Synaptic growth signaling requires proper endosomal trafficking 
 Regulation of endosomal traffic is a critical component of synaptic growth and 
development. Growth signals released during activity, such as the Wnts and BMPs 
described above, bind to synaptic transmembrane receptors and are internalized as 
receptor-ligand signaling complexes. These signaling complexes are transported within 
the endosomal system, in which receptors signal from an early endosome population 
before signal inactivation in the recycling endosome or lysosome (Figure 2). Many of the 
synaptic growth mutants identified in Drosophila alter endocytic trafficking, with 
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mutants that disrupt formation of signaling endosomes causing reduced synaptic growth, 
and mutants altering traffic to the recycling endosome or lysosome causing synaptic 
overgrowth due to enhanced signaling [44,45]. Retrograde transport of signaling 
endosomes containing neurotrophins is also important for neuronal survival and may be 
disrupted in neurodegenerative diseases such as Alzheimer’s and Down’s syndrome [46].  
The hereditary spastic paralegias (HSPs) are a group of neurological disorders 
caused by mutations in several genes which regulate the endosomal trafficking of BMP 
receptors [39,47]. Mutation of the early endosomal HSP gene NIPA1 results in less 
efficient sorting of the type II BMP receptor to the lysosome, suggesting that HSP 
etiology may involve upregulation of BMP signaling due to altered endocytic trafficking 
[47]. Disruption of endosomal function is also implicated in neurodevelopmental 
disorders, including autism and attention-deficient/hyperactivity disorder, for which 
recent genome-wide association and copy number variation studies have implicated the 
Na+/H+ exchangers 6 and 9 (NHE6, 9) [48,49]. NHE6 and 9 are thought to fine-tune the 
pH of early endosomes, disruption of which may alter ligand-receptor dissociation and 
lead to abnormal synaptic growth signaling [50]. Endosomal regulation of signaling 
pathways involved in synaptic growth and development appears critical for activity-
dependent circuit refinement. 
 
Conclusion 
 Abnormal synaptic development is thought to underlie multiple 
neurodevelopmental disorders which present with clinically distinct phenotypes. Altered 
synaptic structure or function may also lead to changes in neuronal connectivity which 
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predisposes an individual to neurodegenerative disease. We have highlighted several 
genes implicated in neuropsychiatric disease which have defined roles in synaptic 
development. Mutations in different genes or gene combinations may lead to a similar 
disease phenotype; thus understanding common molecular pathways in which these genes 
function is important for unraveling disease pathogenesis. Recent advances in genome 
sequencing and large scale genetic screening has identified numerous susceptibility loci 
which converge on pathways involved in synaptogenesis. Our understanding of the basic 
biology of synaptic growth and development is critical to furthering our understanding of 




Fig. 1. Proteins implicated in neuropsychiatric disorders that participate in synaptic 
growth and development. Formation of a functional synapse requires transsynaptic 
interaction of cell adhesive proteins, organization of synaptic domains by scaffolding 
proteins, intercellular growth signaling pathways, actin cytoskeletal remodeling, and 
endosomal trafficking of receptor-ligand signaling complexes. Many of the proteins 
associated with brain disorders have been implicated in these processes.  
 
Fig. 2. Endosomal regulation of synaptic growth signaling pathways. Growth signals 
released during neuronal activity, including Wnts and BMPs, bind to presynaptic 
receptors and are internalized as receptor-ligand signaling complexes. These complexes 
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signal from early endosomes, and are recycled to the plasma membrane through the 
recycling endosome or degraded in the lysosome.  
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